What is HC Wainwright’s Estimate for CVE:HIV Q1 Earnings?

HIVE Blockchain Technologies Ltd. (CVE:HIVFree Report) – Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for HIVE Blockchain Technologies in a note issued to investors on Thursday, November 14th. HC Wainwright analyst M. Colonnese expects that the company will post earnings of ($0.04) per share for the quarter. HC Wainwright has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q2 2026 earnings at $0.00 EPS, Q3 2026 earnings at $0.06 EPS and FY2026 earnings at $0.06 EPS.

Other equities analysts have also recently issued research reports about the company. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th.

View Our Latest Stock Analysis on HIVE Blockchain Technologies

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies (CVE:HIVGet Free Report) last posted its earnings results on Monday, August 12th. The company reported C($0.11) earnings per share for the quarter, missing the consensus estimate of C($0.10) by C($0.01). The company had revenue of C$44.11 million for the quarter, compared to analyst estimates of C$43.64 million.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Featured Articles

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.